Sinorda is a biotech company focusing on the innovative drug development in China with wide cooperation with industries, academic researches, CMOs and CROs and authorities. Sinorda has projects portfolio in clinical phases and experienced management team integrated from China, US and EU regions that can secure project development in low cost, low risk and fast launch on market. Sinorda aims to be an innovative, strong and fast growing pharmaceutical company in China with fast IPO in financial market.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
X842 and Sentinel Node T cell Immunotherapy
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):